P51531 (SMCA2_HUMAN) Homo sapiens (Human)
Probable global transcription activator SNF2L2 UniProtKBInterProSTRINGInteractive Modelling
1590 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
19 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; Q15369; Q15370; | 100 | 1×FX8; 11×EDO; 1×FMT; | |||
| Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:Elong… |
Heteromer P40337; Q15369; Q15370; | 100 | 1×GOL; 1×FWZ; | |||
| Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… |
Heteromer P40337; Q15369; Q15370; | 100 | 1×IFF; | |||
| Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:El… |
Heteromer P40337; Q15369; Q15370; | 100 | 7×EDO; 4×NA; 2×PEG; 1×87A; | |||
| Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; Q15369; Q15370; | 100 | 8×EDO; 1×FWZ; 1×EPE; | |||
| Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC… |
Heteromer P40337; Q15369; Q15370; | 100 | 7×IOD; 1×IFJ; | |||
| Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; Q15369; Q15370; | 100 | 1×IEI; | |||
| Crystal structure of human BRM in complex with compound 16 | homo-2-mer | 100 | 2×J7J; 4×IPA; | |||
| Crystal structure of the bromodomain of human SMARCA2 in complex with SMARCA-BD ligand | homo-2-mer | 100 | 2×FX5; 2×ZN; | |||
| Crystal structure of human BRM in complex with compound 15 | monomer | 100 | 1×J7G; 6×EOH; | |||
| Discovery of Potent, Highly Selective and Efficacious SMARCA2 Degraders - Compound 13 | monomer | 100 | 1×A1A1O; 1×ZN; 1×ACT; | |||
| Discovery of Potent, Highly Selective and Efficacious SMARCA2 Degraders - Compound 6 | monomer | 100 | 1×A1A1P; 1×ZN; 1×ACT; | |||
| Crystal structure of the bromodomain of human BRM (SMARCA2) in complex with a hydroxyphenyl propeno… | monomer | 100 | 2×ZN; 1×5C0; | |||
| Crystal structure of compound 4 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… | monomer | 100 | 1×IF8; 2×ZN; | |||
| Discovery of Potent, Highly Selective and Efficacious SMARCA2 Degraders - Compound 11 | monomer | 100 | 1×A1BF5; 1×ZN; | |||
| BRM (SMARCA2) Bromodomain in complex with ligand 10 | monomer | 100 | 2×ZN; 1×VLC; | |||
| Crystal structure of the bromodomain of human BRM (SMARCA2) in complex with PFI-3 chemical probe | monomer | 100 | 1×ZN; 1×5BW; | |||
| Crystal structure of the bromodomain of human SMARCA2 | monomer | 100 | 1×ZN; | |||
| Solution structure of the Bromodomain of human SWI/SNF related matrix associated actin dependent re… | monomer | 100 | ||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8g1p.2.D | monomer | 0.69 | 100.00 | |||
| 7y8r.1.J | monomer | 0.61 | 1×MG; 1×BEF; | 85.46 | ||
| 7vdv.1.J | monomer | 0.58 | 1×BEF; 1×MG; | 79.87 | ||
| 5hzr.1.A | monomer | 0.55 | 1×KH2; | 58.25 | ||
| 7egp.1.H | monomer | 0.52 | 1×BEF; 1×MG; | 47.49 | ||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8g1p.2.D | monomer | 0.80 | 100.00 | |||
| Isoform 2 | 7y8r.1.J | monomer | 0.61 | 1×MG; 1×BEF; | 78.52 | ||
| Isoform 2 | 5hzr.1.A | monomer | 0.60 | 1×KH2; | 60.46 | ||
| Isoform 2 | 7vdv.1.J | monomer | 0.58 | 1×BEF; 1×MG; | 79.93 | ||
| Isoform 2 | 7egp.1.H | monomer | 0.52 | 1×BEF; 1×MG; | 47.60 | ||